Botulinum Toxin Type A Versus Cross-Linked Hyaluronic Acid Filler Myomodulation for Non-Surgical Management of Excessive Gingival Display

NCT07715331 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Excessive Gingival Display
Gingival Diseases
Gummy Smile
Esthetics, Dental

Interventions

DRUG: Botulinum Toxin Type A (Refinex®)
DRUG: Cross-Linked Hyaluronic Acid Filler (Juvéderm Voluma® with Lidocaine)

Sponsor

Al-Azhar University